Acceder

Cotización de Arrowhead Pharmaceuticals, Inc. (ARWR) hoy en tiempo real

Arrowhead Pharmaceuticals, Inc. (ARWR)

Análisis técnico y gráfico histórico de Arrowhead Pharmaceuticals, Inc.

Análisis fundamental y estadísticas clave de Arrowhead Pharmaceuticals, Inc.

Ficha de Arrowhead Pharmaceuticals, Inc. (ARWR)

Ticker ARWR
ISIN US04280A1007
Sector Atención sanitaria
Mercado NASDAQ

Análisis financiero de Arrowhead Pharmaceuticals, Inc.

Briefing Valoración Rentabilidad Métricas por acción Deuda Liquidez

Resumen financiero e información corporativa de Arrowhead Pharmaceuticals, Inc.

Invertir en Arrowhead Pharmaceuticals, Inc. en 2026: Preguntas frecuentes

¿Qué es Arrowhead Pharmaceuticals, Inc.?

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, which is in phase 2b and one phase 3 clinical trial to treat hypertriglyceridemia; ARO-ANG3 that is in Phase 2b clinical trial to reduce production of ...

¿En qué sector opera Arrowhead Pharmaceuticals, Inc.?

Arrowhead Pharmaceuticals, Inc. opera en el sector Healthcare, industria Biotechnology.